Stocks · News reference

Piper Sandler Maintains Neutral on Fulgent Genetics, Raises Price Target to $19

Aug 4, 2026, 2:35 PMBenzinga Newsdesk

Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and raises the price target from $15 to $19.

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Aug 4, 2026, 2:35 PM
Checked: Aug 4, 2026, 2:35 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaJul 31, 2026, 1:21 PMBenzinga Newsdesk
Fulgent Genetics shares are trading lower after the company reported worse-than-expected Q2 financial results and lowered its FY2026 adjusted EPS and FY2026 sales guidance.
Read original at benzinga
FLGT
BenzingaJul 31, 2026, 12:03 PMAvi Kapoor
Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures rise, Nasdaq 100 up 300 points. Apple Inc shares fall 7.4% despite beating analyst estimates for Q3. Other stocks also dip in pre-market.
Read original at benzinga
AAPL AIRS CERS COIN FLGT
BenzingaJul 30, 2026, 8:19 PMBenzinga Newsdesk
Fulgent Genetics Lowers FY2026 Adj EPS Guidance from $(1.59) to $(2.35)-$(2.22) vs $(1.55) Est; Lowers FY2026 Sales Guidance from $350.000M to $330.000M-$340.000M vs $351.900M Est
Read original at benzinga
FLGT